{"disease":{"id":"minimal-disease-residual","name":"minimal disease residual"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03330769","title":"Ultrasound in Psoriatic Arthritis Treatment","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"University of Cagliari","has_results":false},{"nct_id":"NCT03564977","title":"CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Qingdao Central Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}